spacer
home > ict > summer 2019 > choosing a winning model
PUBLICATIONS
International Clinical Trials

Choosing a Winning Model





How you approach implementing functional service provision (FSP) within your company has a direct effect on how successful those FSP teams will be. A ‘sustainable quality’ approach starts with picking the right model and navigating several areas of focus to ensure its success: planning, training, cultural fit, staff retention, technology, communication, agility, sponsor participation, performance indicators, expectations management, etc.

There are four basic models: uncapped time and materials (T&M), capped T&M, fixed fee, and ring-fenced/ full-time equivalents (FTEs) − each with pros and cons based on trial requirements and real-world experience.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
About the author


Jo Marshall is the Director of FSP and UK Country Manager for CROS NT. Jo entered the industry as a clinical data manager for Searle and held global data management roles for Pharmacia and Pfizer before moving to a specialist biometrics consultancy and contributing to the growth of that company first as Associate Director, then Managing Director until its sale to CROS NT in 2013. Since being at CROS, she has supported a variety of initiatives including commercial, quality, efficiency, and product development, as well as operational department management for the statistical programming team. She holds an MSc in Clinical Data Management, is the treasurer for the Association for Clinical Data Management (ACDM), and chaired the ACDM conference organising committee for a number of years.


Print this page
Send to a friend
Privacy statement
News and Press Releases

Prince Helps Sustainable Pharma Packaging Pioneers Woolcool Celebrate 10th Anniversary

Ground-breaking sustainable pharma packaging firm Woolcool celebrated a decade of innovation with a visit by HRH The Prince of Wales.
More info >>

White Papers

The Role of the CRO in Effective Risk-Based Monitoring

Medpace

The clinical trial industry is evolving. In an effort to improve participant safety and data integrity, regulators are encouraging trial sponsors to transition from a focused on-site monitoring approach they have traditionally employed toward a risk-based approach that utilizes a combination of centralized and on-site monitoring techniques to ensure patient safety and data quality. The Risk-Based Monitoring (RBM) paradigm has many potential advantages over established monitoring practices including enhanced patient safety and data integrity, more efficient and effective protocol design, reduced costs, and the ability to strategically adjust oversight in keeping with changes in risk level.
More info >>

 
Industry Events

SCOPE Summit for Clinical Ops Executives

18-21 February 2020, Hyatt Regency, Orlando, Florida, US

Celebrating its 11th successful year, SCOPE Summit 2020 takes place February 18-21 in Orlando, FL. Over the course of four stimulating days of in-depth discussions in 20 different conferences, 3 plenary keynote sessions, the annual Participant Engagement Awards, and the ever-popular interactive breakout discussions, the programming focuses on advances and innovative solutions in all aspects of clinical trial planning, management and operations
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement